ESC Cardio Talk

European Society of Cardiology
undefined
Nov 24, 2025 • 7min

Journal editorial - The emerging story of Myval transcatheter heart valve: lessons from the LANDMARK trial

Paolo Springhetti, a Milanese cardiologist specializing in transcatheter valve therapies, joins Marie-Annick Clavel to discuss the LANDMARK trial findings. They dive into the unique sizing advantages of Myval compared to competitors, highlighting impressive hemodynamic outcomes. Sex-specific definitions of patient-prosthesis mismatch (PPM) come under scrutiny, revealing stark differences among valve types. The duo also explores the implications of Myval's low-flow recovery and durability concerns for younger patients, emphasizing the need for long-term studies.
undefined
Nov 17, 2025 • 9min

Journal editorial: The dilemma of a correct patient selection for implantable cardioverter defibrillator in non-ischaemic cardiomyopathy

With Domenico Filomena, Polyclinic Umberto I, Rome - Italy and Luciano Agati Sapienza, University of Rome, Rome - Italy. Link to European Heart Journal paper Link to European Heart Journal editorial
undefined
Nov 10, 2025 • 11min

Journal editorial: Is routine imaging follow-up after LAA closure necessary?

With Jonathan Lessick, Rambam Health Care Campus, Haifa - Israel and Mahmoud Suleiman, Rambam Health Care Campus, Haifa - Israel. Link to European Heart Journal paper Link to European Heart Journal editorial
undefined
Oct 20, 2025 • 11min

Journal Editorial: Perioperative discontinuation of renin–angiotensin system inhibitors in non-cardiac surgery: is it time to change what we tell our patients?

With Maura Marcucci, Clinical Institute Humanitas IRCCS, Rozzano - Italy and McMaster University, Hamilton - Canada and Mauro Chiarito, Clinical Institute Humanitas IRCCS, Rozzano - Italy and Icahn School of Medicine at Mount Sinai, NYC - USA. Link to European Heart Journal paper Link to European Heart Journal editorial
undefined
Oct 20, 2025 • 10min

Journal editorial: Arrhythmic risk and advanced heart failure in dilated cardiomyopathy: a deadly tango

With Jean-Benoit Le Polain de Waroux, St-Jan Hospital, Brugge - Belgium, and Maarten De Smet, AZ Sint Jan, Brugge - Belgium. Link to European Heart Journal paper Link to European Heart Journal editorial
undefined
Oct 6, 2025 • 13min

Journal editorial: ApoB and Lp(a): core measures to assess cardiovascular risk

Allan Sniderman, a cardiologist and professor at McGill University, dives into the importance of ApoB and Lp(a) for cardiovascular risk assessment. He challenges traditional views on VLDL versus LDL atherogenicity, revealing that VLDL may pose greater risks than previously thought. Sniderman discusses a comprehensive study involving over 200,000 participants, elaborating on how examining particle numbers can change risk interpretations. He advocates for measuring ApoB and Lp(a) to enhance clinical insights and streamline patient care.
undefined
Sep 29, 2025 • 12min

Journal editorial: With a little HELP from heparin at first medical contact before primary percutaneous coronary intervention

With David Erlinge and Sasha Koul, Lund University, Lund - Sweden Read the European Heart Journal paper Read the European Heart Journal editorial
undefined
Sep 15, 2025 • 11min

Journal editorial - Residual cardiovascular risk beyond low-density lipoprotein cholesterol: inflammation, remnant cholesterol, and lipoprotein(a)

With Børge Nordestgaard and Anders Berg Wulff, Copenhagen University Hospital, Copenhagen - Denmark. Read the European Heart Journal - Cardiovascular Imaging paper Read the European Heart Journal - Cardiovascular Imaging editorial
undefined
Aug 4, 2025 • 16min

Journal editorial - Has artificial intelligence proven stress perfusion cardiac computed tomography obsolete or more relevant than ever?

With Edward Hulten, Brown University, Providence, and Islam Shatla, University of Kansas Medical Center, Kansas City, USA. Link to editorial Link to paper
undefined
Jul 12, 2025 • 7min

Journal editorial - When coronary plaque is found in everyone: is anyone really at risk?

With Francesca Coraducci Marche Polytechnic University of Ancona, Ancona - Italy, Marco Guglielmo, University Medical Center Utrecht, Utrecht - The Netherlands, and Anna Giulia Pavon, Cardiocentro Ticino Institute, Lugano - Switzerland. Link to editorial Link to paper

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app